Table 2 Operation time, number of ligated vessels and complications in the LigaSure and conventional ligation Group.
From: Randomized clinical trial of LigaSure versus conventional suture ligation in thyroid surgery
LigaSure (n = 20) | Conventional (n = 20) | P | |
|---|---|---|---|
Primary endpoint | |||
Total operation time (min); median (range) | 56 (37-70) | 66 (48-99) | 0.001 |
Secondary endpoints | |||
Length of operation phases (min); median (range) | |||
Operation phase I | 16 (9-20) | 17 (12-28) | N.S.a |
Operation phase II | 29 (17-40) | 38 (21-50) | < 0.001 |
Operation phase III | 12 (7-26) | 11 (7-16) | N.S. |
Number of ligated vessels; median (range) | |||
Operation phase I | 1 (0-3) | 1 (0-4) | N.S. |
Operation phase II | 14 (8-32) | 8 (3-12) | < 0.001 |
Operation phase III | 3 | 0 | N.S. |
Total | 16 (8-34) | 9 (4-16) | < 0.001 |
Number of patients with complicated postoperative course | 2 | 0 | N.S. |